Skip to content

D&A at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$229M+11.2%
UnitedHealth Group logo
UnitedHealth GroupUNH
$1.03B-3.0%
Encompass Health Corporation logo
Encompass Health CorporationEHC
$87.3M+10.2%
HCA Healthcare logo
HCA HealthcareHCA
$930M+8.1%
Astrana Health logo
Astrana HealthASTH
$15.48M+126%
Solventum logo
SolventumSOLV

Segments

By segment

See full
Surgical Facilities$38.5M+6.1%

Other financials

Income statement

See full
Revenue$810.9M+4.5%
Operating income$65.8M+6.3%
Net income-$35.9M+4.8%
EPS (diluted)-$0.28+6.7%

Balance sheet

See full
Cash & equivalents$182.3M-20.5%
Total debt$5.1B+4.6%
Total equity$1.7B-3.0%
Total assets$8.0B+1.2%

Cash flow

See full
Operating cash flow$11.7M+95.0%
CapEx$16.0M-29.5%
Free cash flow-$4.3M+74.3%

Valuation

See full
Market cap$1.9B-49.1%
Enterprise value$6.77B-16.0%
P/S0.6×-0.6×

Profitability

See full
Gross margin23.1%
Operating margin11.8%+1.2pp
Net margin-2.3%-0.9pp
FCF margin6.2%+0.8pp

Returns & leverage

See full
Return on equity-4.4%-1.6pp
Debt / equity+0.2×
Current ratio1.9×0.0×

Where this comes from

Reported directly by Surgery Partners, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Surgery Partners, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Surgery Partners, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Surgery Partners, Inc.'s D&A?
Surgery Partners, Inc. (SGRY) reported D&A of $38.5M in Q1 2026.
How has Surgery Partners, Inc.'s D&A changed year-over-year?
Surgery Partners, Inc.'s D&A increased by 6.1% year-over-year, from $36.3M to $38.5M.
What is the long-term trend for Surgery Partners, Inc.'s D&A?
Over 4 years (2021 to 2025), Surgery Partners, Inc.'s D&A has grown at a 15.5% compound annual growth rate (CAGR), from $98.8M to $176M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.